Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJC8P3, or DNAJC8 pseudogene, is a genomic DNA sequence resembling the functional DNAJC8 gene but lacks the necessary coding potential and/or regulatory elements to produce a functional protein due to mutations or genomic alterations[5]. Pseudogenes typically arise via gene duplication or retrotransposition, resulting in non-functional copies that may accumulate mutations more rapidly, free from selective pressure[5]. They are often *not* considered therapeutic targets, nor do they participate in typical molecular functions, disease pathways, or have drug interactions expected for the protein-coding gene. Some pseudogenes can have regulatory roles in gene expression, but there is currently no strong evidence supporting such a function for DNAJC8P3 specifically[5]. Additional context: - DNAJC8 (the parent gene) encodes a member of the HSP40 family involved in protein folding and cell cycle regulation, with potential involvement in cancer biology[1][3][4]; *the pseudogene does not perform these functions*. - Care should be taken to distinguish between functional genes and their pseudogene counterparts when evaluating therapeutic utility or molecular function. This entry refers to a **pseudogene**, which is not a protein, enzyme, transporter, or receptor, and is outside the scope of typical drug target discovery pipelines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJC8 pseudogene (DNAJC8P3).